세계의 재구성 약물용 바이알 어댑터 시장 보고서(2025년)
Vial Adaptors For Reconstitution Drug Global Market Report 2025
상품코드 : 1760736
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,618,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,566,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,515,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

재구성 약물용 바이알 어댑터 시장 규모는 향후 몇 년 동안 10.9%의 연평균 복합 성장률(CAGR)로 2029년까지 30억 5,000만 달러에 달할 것으로 예측됩니다. 예측 기간 동안의 성장은 생물학적 제제 및 바이오시밀러의 사용 증가, 재택치료 및 자가 투여 증가, 세계 인구의 고령화, 종양학 및 희귀질환 치료의 성장, 교차 오염 위험에 대한 인식 증가에 의해 뒷받침될 것으로 예측됩니다. 예측 기간 동안 예상되는 주요 동향으로는 스마트 기술의 통합, 재료 과학의 발전, 재택치료 및 자가 투여를 위한 맞춤화, 지속 가능하고 환경 친화적인 재료의 채택, 의약품 포장의 지속가능성 강조 등이 있습니다.

만성 질환 증가는 향후 몇 년 동안 재구성 약물용 바이알 어댑터 시장의 성장을 가속할 것으로 예측됩니다. 만성질환은 지속적인 치료가 필요하고 1년 이상 지속될 수 있는 장기적인 건강 상태입니다. 만성질환 증가는 가공식품의 소비와 좌식 생활습관 증가로 인해 신체의 자연적 방어력을 약화시켜 장기적인 건강 문제의 원인이 되고 있습니다. 생물학적 제제 및 동결건조 제제를 안전하고 효율적으로 재구성하고 투여하기 위해 만성질환 치료에는 일반적으로 재구성 약물용 바이알 어댑터가 사용되지만, 이는 종종 장기간의 치료 기간이 필요합니다. 예를 들어, 2023년 7월 영국의 독립 자선단체인 The Health Foundation은 2040년까지 영국에서 910만 명이 큰 질병을 앓고 있으며, 이는 현재보다 250만 명이 증가할 것으로 예측했습니다. 이에 따라 만성질환의 유병률이 증가하고 재구성 약물용 바이알 어댑터에 대한 수요가 증가할 것으로 예측됩니다.

재구성 약물 바이알 어댑터 시장의 주요 업체들은 혼합 주입 장치와 같은 첨단 제품 개발에 주력하고 있습니다. 이러한 장치는 약물 재구성의 정확성을 높이고, 오염 위험을 최소화하며, 약물 준비 및 투여의 전반적인 효율성을 향상시키도록 설계되었습니다. 혼합 주입 장치는 의약품, 특히 생물학적 제제나 동결건조 의약품을 사용 전에 희석제와 결합하여 안전하고 정확하게 혼합하거나 재구성할 수 있도록 도와주는 의료용 도구입니다. 예를 들어, 2023년 12월, 미국에 본사를 둔 혁신적인 주사제 전달 시스템을 제공하는 West Pharmaceutical Services, Inc.는 Vial2Bag Advanced 13mm 혼합 장치(Vial2Bag Advanced 13mm)에 대한 FDA 510(k) 승인을 획득했습니다. 이 신제품은 기존 20mm 버전을 보완하는 제품으로, 의료 서비스 제공업체에게 13mm 또는 20mm 바이알 및 IV 백을 사용하여 약물을 재구성하고 주입할 수 있는 유연하고 바늘이 필요 없는 솔루션을 제공합니다. 효율적인 유체 경로를 위한 듀얼 채널 설계와 견고한 바이알 스파이크(vial spike)를 통해 안전한 연결을 보장하는 이 장치는 임상 현장에서의 안전성과 사용 편의성을 향상시킵니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

LSH
영문 목차

영문목차

Vial adaptors for reconstitution drugs are medical devices designed to safely and efficiently mix a powdered medication in a vial with a diluent prior to administration. They aim to reduce contamination risk, ensure accurate dosing, and streamline the drug preparation process for healthcare professionals.

The main product categories include single-use vial adaptors, multi-use vial adaptors, and customized vial adaptors. Single-use vial adaptors are sterile, disposable devices intended for safe medication transfer or reconstitution from a vial for a single use, promoting contamination prevention and patient safety. These adaptors are manufactured using materials such as polycarbonate, silicone, polyethylene, and others, and are applied in areas such as oncology, autoimmune disorders, infectious diseases, genetic conditions, and hormone replacement therapy. Primary end users include pharmaceutical companies, contract manufacturing organizations, research institutions, hospitals, and retail pharmacies.

The vial adaptors for reconstitution of drug market research report is one of a series of new reports from The Business Research Company that provides vial adaptors for reconstitution of drug market statistics, including the vial adaptors for reconstitution of drug industry global market size, regional shares, competitors with the vial adaptors for reconstitution of drug market share, detailed vial adaptors for reconstitution of drug market segments, market trends, and opportunities, and any further data you may need to thrive in the vial adaptors for reconstitution of drug industry. This vial adaptors for reconstitution of drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The vial adaptors for reconstitution drug market size has grown rapidly in recent years. It will grow from $1.81 billion in 2024 to $2.01 billion in 2025 at a compound annual growth rate (CAGR) of 11.2%. Growth during the historic period was driven by the rising prevalence of chronic diseases, increasing demand for safe drug administration, expansion of parenteral drug use, development of hospital and healthcare infrastructure, and greater adoption of single-dose vials.

The vial adaptors for reconstitution drug market size is expected to see rapid growth in the next few years. It will grow to $3.05 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. Growth in the forecast period is expected to be supported by the increasing use of biologics and biosimilars, the rise of home healthcare and self-administration, an aging global population, growth in oncology and rare disease treatments, and heightened awareness of cross-contamination risks. Key trends anticipated for the forecast period include the integration of smart technologies, advances in material science, customization for home healthcare and self-use, adoption of sustainable and eco-friendly materials, and a focus on sustainability in pharmaceutical packaging.

The increasing prevalence of chronic diseases is anticipated to drive the growth of the vial adaptors for reconstitution drug market in the coming years. Chronic diseases are long-term health conditions that require ongoing medical care and can persist for a year or more. The rise in chronic conditions is largely due to the growing consumption of processed foods and sedentary lifestyles, which weaken the body's natural defenses and contribute to long-term health issues. Vial adaptors for reconstitution drugs are commonly used in the treatment of chronic diseases to safely and efficiently reconstitute and administer biologic or lyophilized medications, which are often required for extended treatment periods. For example, in July 2023, The Health Foundation, a UK-based independent charity, projected that by 2040, 9.1 million people in England will be living with a major illness, an increase of 2.5 million from current figures. As a result, the rising incidence of chronic diseases is expected to drive demand for vial adaptors for reconstitution drugs.

Major players in the vial adaptors for reconstitution drug market are focusing on developing advanced products such as admixture devices. These devices are designed to enhance the precision of drug reconstitution, minimize contamination risks, and improve overall efficiency in preparing and administering medications. An admixture device is a medical tool that facilitates the safe and accurate mixing or reconstitution of drugs, especially biologics or lyophilized medications, by combining the drug with a diluent before use. For instance, in December 2023, West Pharmaceutical Services, Inc., a U.S.-based provider of innovative injectable drug delivery systems, received FDA 510(k) clearance for its Vial2Bag Advanced 13mm admixture device. This new product complements the existing 20mm version, offering healthcare providers flexible, needle-free solutions for drug reconstitution and transfer with either 13mm or 20mm vials and IV bags. Featuring a dual-channel design for efficient fluid pathways and a robust vial spike for secure connection, the device improves safety and ease of use in clinical settings.

In November 2024, Amsino Medical Group, a U.S.-based medical device manufacturer, acquired MedXL Inc. for an undisclosed amount. This acquisition allows Amsino to significantly increase its production capacity, enabling the company to meet the growing demand for medical devices, including vial adapters. The expanded manufacturing capabilities will help Amsino continue to supply high-quality medical products to healthcare providers. MedXL Inc. is a Canada-based manufacturer specializing in vial adapters for drug reconstitution.

Major players in the vial adaptors for reconstitution drug market are Medline Industries LP, Becton Dickinson and Company, Baxter International Inc., B. Braun SE, Nipro Corporation, West Pharmaceutical Services Inc., Stevanato Group S.p.A., Miltenyi Biotec B.V. & Co. KG, Vygon SA, Helapet Limited, Union Plastic S.A.S., MedXL Inc., Amsino International Inc., Simplivia Healthcare Ltd., Yukon Medical LLC, Corvida Medical Inc., Dedecke GmbH, Medtec Medical Inc., APG Pharma B.V., and Conserva UK Limited.

North America was the largest region in the vial adaptors for reconstitution drug market in 2024. The regions covered in vial adaptors for the reconstitution drug report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the vial adaptors for the reconstitution drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vial adaptors for the reconstitution drug market consist of sales of closed-system vial adaptors, Luer-lock vial adaptors, universal vial adaptors, and vented vial adaptors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vial Adaptors For Reconstitution Drug Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vial adaptors for reconstitution drug market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for vial adaptors for reconstitution drug ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vial adaptors for reconstitution drug market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Vial Adaptors For Reconstitution Drug Market Characteristics

3. Vial Adaptors For Reconstitution Drug Market Trends And Strategies

4. Vial Adaptors For Reconstitution Drug Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Vial Adaptors For Reconstitution Drug Growth Analysis And Strategic Analysis Framework

6. Vial Adaptors For Reconstitution Drug Market Segmentation

7. Vial Adaptors For Reconstitution Drug Market Regional And Country Analysis

8. Asia-Pacific Vial Adaptors For Reconstitution Drug Market

9. China Vial Adaptors For Reconstitution Drug Market

10. India Vial Adaptors For Reconstitution Drug Market

11. Japan Vial Adaptors For Reconstitution Drug Market

12. Australia Vial Adaptors For Reconstitution Drug Market

13. Indonesia Vial Adaptors For Reconstitution Drug Market

14. South Korea Vial Adaptors For Reconstitution Drug Market

15. Western Europe Vial Adaptors For Reconstitution Drug Market

16. UK Vial Adaptors For Reconstitution Drug Market

17. Germany Vial Adaptors For Reconstitution Drug Market

18. France Vial Adaptors For Reconstitution Drug Market

19. Italy Vial Adaptors For Reconstitution Drug Market

20. Spain Vial Adaptors For Reconstitution Drug Market

21. Eastern Europe Vial Adaptors For Reconstitution Drug Market

22. Russia Vial Adaptors For Reconstitution Drug Market

23. North America Vial Adaptors For Reconstitution Drug Market

24. USA Vial Adaptors For Reconstitution Drug Market

25. Canada Vial Adaptors For Reconstitution Drug Market

26. South America Vial Adaptors For Reconstitution Drug Market

27. Brazil Vial Adaptors For Reconstitution Drug Market

28. Middle East Vial Adaptors For Reconstitution Drug Market

29. Africa Vial Adaptors For Reconstitution Drug Market

30. Vial Adaptors For Reconstitution Drug Market Competitive Landscape And Company Profiles

31. Vial Adaptors For Reconstitution Drug Market Other Major And Innovative Companies

32. Global Vial Adaptors For Reconstitution Drug Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vial Adaptors For Reconstitution Drug Market

34. Recent Developments In The Vial Adaptors For Reconstitution Drug Market

35. Vial Adaptors For Reconstitution Drug Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기